INTERNATIONAL PATENT: ARTAX BIOPHARMA INC. FILES APPLICATION FOR "COMBINATION OF A CAR-T THERAPY AND A CHROMENE DERIVATIVE TCR INHIBITOR"

GENEVA, Dec. 17 -- ARTAX BIOPHARMA INC. (1 Broadway, 14th FloorCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/032042) for "COMBINATION OF A CAR-T THERAPY AND A CHROMENE DERIVATIVE TCR INHIBITOR" on Jun 03, 2025. With publication no. WO/2025/255093, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VANDEUSEN, Christopher Loren (c/o Artax Biopharma Inc.1 Broadway, 14th FloorCambridge, Massachusetts 02142), ALARCON SANCHEZ, Balbino Jose (c/o Fundacion Severo Ochoac/ Nicolas Cabrera 128049 Madrid), HORND...